# Clinical trials recruiting in Romania: 446 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 446 trials recruiting or not yet recruiting with a site in Romania, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Romania: 446 rows for $22.30, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 7 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/romania

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 446
- Recruiting or not yet: 446
- Read on: November 19, 2026

## Trials

The 25 newest of 446, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 4, 2026 | NCT07916155 | Effects of Virtual Reality Exergaming on Reaction Time, Physical Performance, and Muscle Activity in Children | Babes-Bolyai University | Not applicable | Not yet recruiting | Neuromuscular Performance, Reaction Time, Postural Balance | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916155) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| October 30, 2026 | NCT07907224 | Characterization of Small Intestinal Bacterial Overgrowth and Intestinal Barrier-Related Biomarkers in Patients With Severe Periodontitis | Iuliu Hatieganu University of Medicine and Pharmacy | Observational | Recruiting | Periodontitis (Stage 3), Periodontitis Stage IV, SIBO | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907224) |
| October 28, 2026 | NCT07902141 | A Web-based Intervention Program for Postpartum Depression | Babes-Bolyai University | Early phase 1 | Recruiting | Postpartum Depression (PPD), Web-based Intervention | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902141) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 21, 2026 | NCT07885891 | Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia | Wockhardt | Phase 3 | Not yet recruiting | Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885891) |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881458) |
| October 19, 2026 | NCT07881133 | Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery | Bucharest Emergency Hospital | Not applicable | Recruiting | Colorectal (Colon or Rectal) Cancer, STOMACH NEOPLASM | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881133) |
| October 16, 2026 | NCT07878858 | Equivalence of Systolic Blood Pressure Measurements Between Fowler and Seated Positions | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Not yet recruiting | Blood Pressure Measurement | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878858) |
| October 16, 2026 | NCT07878767 | Pilot Study: Evaluation of the Safety of the Application of Non-thermal HIFU for Varicose Veins Treatment of the Lower Limbs | VeinSound | Not applicable | Recruiting | Superficial Venous Insufficiency, Varicose Veins | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878767) |
| October 15, 2026 | NCT07875582 | Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma | Grigore T. Popa University of Medicine and Pharmacy | Observational | Recruiting | Pancreatic Cancer, Chronic Pancreatitis, Intraductal Papillary Mucinous Neoplasm, Mucinous Cystic Neoplasm | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875582) |
| October 13, 2026 | NCT07871214 | A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage... | Bristol-Myers Squibb | Phase 2 | Not yet recruiting | Early-Stage Non-Small Cell Lung Cancer | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871214) |
| September 30, 2026 | NCT07850453 | Vortosiran for VTE Prevention | Ribocure Pharmaceuticals AB | Phase 2 | Not yet recruiting | Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850453) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 16, 2026 | NCT07821554 | Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pancreatic Cancer | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821554) |
| August 27, 2026 | NCT07789015 | A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Idiopathic Inflammatory Myopathies | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789015) |
| August 25, 2026 | NCT07786220 | Cognitive Load and Inhaler Technique in COPD | Sponsor not shown (see the record) | Not applicable | Recruiting | COPD | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786220) |
| August 17, 2026 | NCT07768189 | A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma | Corbus Pharmaceuticals Inc. | Phase 3 | Recruiting | Oropharyngeal Carcinoma (OPC) | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768189) |
| August 13, 2026 | NCT07762027 | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection | Assembly Biosciences | Phase 2 | Not yet recruiting | Chronic Hepatitis D Infection | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762027) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 12, 2026 | NCT07759245 | A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) | Eli Lilly and Company | Phase 2 | Recruiting | Pulmonary Disease, Chronic Obstructive | 606 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759245) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Institutul Clinic Fundeni | Bucharest | 22 |
| Institutul Oncologic Cluj | Cluj-Napoca | 17 |
| Institutul Regional de Oncologie | Iași | 17 |
| Centrul de Oncologie "Sfântul Nectarie" | Craiova | 16 |
| Fundeni Clinical Institute | Bucharest | 16 |
| Spitalul Clinic Colentina | Bucharest | 15 |
| SC Radiotherapy Center Cluj SRL | Florești | 11 |
| Institutul Regional de Oncologie Iasi | Iași | 11 |
| Delta Health Care | Bucharest | 9 |
| Cabinet Medical Oncomed | Timișoara | 8 |
| Spitalul Universitar de Urgență București | Bucharest | 8 |
| Prof. Dr. Alexandru Obregia Psychiatry Hospital | Bucharest | 8 |
| Colentina Clinical Hospital | Bucharest | 8 |
| S.C. Centrul de Oncologie Euroclinic S.R.L. | Iași | 8 |
| SC Memorial Healthcare International SRL | Bucharest | 7 |
| Institutul Oncologic Prof. Dr. Ion Chiricuta | Cluj-Napoca | 7 |
| Spitalul Clinic Filantropia | Bucharest | 6 |
| Oncohelp Medical Center | Timișoara | 6 |
| Spitalul Clinic Colțea | Bucharest | 6 |
| Institutul Oncologic Bucuresti "Prof. Dr. Alexandru Trestioreanu" | Bucharest | 5 |
| Spitalul Clinic Judetean de Urgenta Targu Mures | Târgu Mureş | 5 |
| Clinica Korall | Satu Mare | 5 |
| Spitalul de Psihiatrie și Neurologie Brașov | Sanpetru /Brasov | 5 |
| Spitalul Clinic Judetean de Urgenta Bihor | Oradea | 5 |
| SC Radiotherapy Center Cluj SRL-Oncologie Medicala | Cluj-Napoca | 5 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 15 |
| Phase 1/2 | 15 |
| Phase 2 | 50 |
| Phase 2/3 | 23 |
| Phase 3 | 215 |
| Phase 4 | 7 |
| Not applicable | 52 |
| Observational | 68 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 30 |
| Neoplasms | 21 |
| Obesity | 12 |
| Lung Neoplasms | 11 |
| Diabetes Mellitus, Type 2 | 10 |
| Lupus Erythematosus, Systemic | 10 |
| Breast Neoplasms | 10 |
| Crohn Disease | 10 |
| Heart Failure | 10 |
| Pulmonary Disease, Chronic Obstructive | 9 |
| Colitis, Ulcerative | 9 |
| Alzheimer Disease | 8 |
| Overweight | 8 |
| Renal Insufficiency, Chronic | 8 |
| Schizophrenia | 7 |
| Small Cell Lung Carcinoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Stroke | 7 |
| Depression | 7 |
| Leukemia, Myeloid, Acute | 7 |
| Neoplasm Metastasis | 7 |
| Depressive Disorder, Major | 6 |
| Stomach Neoplasms | 6 |
| Atrial Fibrillation | 6 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 30 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 18 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 17 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 15 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 15 |
| Iuliu Hatieganu University of Medicine and Pharmacy | 10 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 10 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 10 |
| Babes-Bolyai University | 10 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 7 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 7 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 6 |
| [Neurocrine Biosciences](https://specstream.ai/data/clinical-trials/company/neurocrine-biosciences) | 6 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 5 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 5 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 5 |
| [Gilead Sciences](https://specstream.ai/data/clinical-trials/company/gilead-sciences) | 5 |
| Grigore T. Popa University of Medicine and Pharmacy | 5 |
| [argenx](https://specstream.ai/data/clinical-trials/company/argenx) | 5 |
| [Karuna Therapeutics, Inc., a Bristol Myers Squibb company](https://specstream.ai/data/clinical-trials/company/karuna-therapeutics-inc-a-bristol-myers-squibb-company) | 4 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 4 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 4 |
| University of Bucharest | 4 |
| [Octapharma](https://specstream.ai/data/clinical-trials/company/octapharma) | 3 |
| CatalYm GmbH | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
- [Energy companies in the United States](https://specstream.ai/data/businesses/energy-companies/united-states)
- [Forklift dealers in the United States](https://specstream.ai/data/businesses/forklift-dealers/united-states)
- [Home staging companies in the United States](https://specstream.ai/data/businesses/home-staging-companies/united-states)
- [IT service companies in the United States](https://specstream.ai/data/businesses/it-service-companies/united-states)
- [Media agencies in the United States](https://specstream.ai/data/businesses/media-agencies/united-states)
